English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis Journal article
Huang, Cong, Ung, Oi Lam Carolina, Wushouer, Haishaerjiang, Bai, Lin, Li, Xinyi, Guan, Xiaodong, Shi, Luwen. Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis[J]. International Journal of Health Policy and Management, 2022, 11(8), 1489–1495.
Authors:  Huang, Cong;  Ung, Oi Lam Carolina;  Wushouer, Haishaerjiang;  Bai, Lin;  Li, Xinyi; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:3.1/3.8 | Submit date：2022/08/28
Price Negotiation  Targeted Anticancer Medicines  Interrupted Time Series  China  
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines? Journal article
Huang, Cong, Ung, Carolina Oi Lam, Wushouer, Haishaerjiang, Bai, Lin, Huang, Tao, Li, Xinyi, Guan, Xiaodong, Shi, Luwen. Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?[J]. Health Research Policy and Systems, 2022, 20(1), 3.
Authors:  Huang, Cong;  Ung, Carolina Oi Lam;  Wushouer, Haishaerjiang;  Bai, Lin;  Huang, Tao; et al.
Favorite | TC[WOS]:10 TC[Scopus]:12  IF:3.6/4.3 | Submit date：2022/05/13
Health Technology Assessment  Pricing Negotiation  Targeted Anticancer Medicines